Previous work from our laboratory have extensively used Transferrin and Insulin (jointly termed here as GF or growth factors) in combination to activate IGF-1R-mediated cell survival signaling in colon cancer cells [23-27]. This evidence concerns the gene IGF1R and colonic neoplasm.